Sanderling Ventures

12 employees

Sanderling Ventures is an investment firm that works on building and funding new biomedical companies.

Investor insights

Sectors invested in

Health Care53

Biotechnology51

Pharmaceutical20

Medical Device20

Medical17

Therapeutics8

Genetics7

Health Diagnostics5

The LINX Reflux Management System for the treatment of GERD and The FENIX Continence Restoration System for the treatment of Fecal Incontinence (FI)5

Genetic Counseling Services5

CMA5

Proprietary Genetic Markers5

Developmental Delay5

Chromosomal Microarray5

Autism Spectrum Disorder5

Exome5

No financial surprises5

M-CHAT.org5

Intellectual Disability5

WES5

Funding rounds participated in

$15M sweet spot round size

Most of their 82 investments are in rounds between $7.5M and $25M

Investor type

Micro VC

Basic info

Industry

venture capital and private equity principals

Sectors

Early Stage Financing

Biotechnology

Financial Services

Information Health

Finance

Medical Devices

Venture Capital

Date founded

1979

Investments made

Undisclosed raised $21M on March 11, 2021

Investors: Valence Life Sciences, Quark Venture and Sanderling Ventures

Undisclosed raised $15M on May 22, 2020

Investors: Valence Life Sciences, Bering Capital and Sanderling Ventures

ViaCyte (formerly Novocell) raised $33M on March 20, 2020

Investors: RA Capital Management, L.P. and Sanderling Ventures

Glycomine Inc. raised $33M on August 7, 2019

Investors: Chiesi Ventures, Mission Bay Capital, Mission BioCapital, Novo Holdings and Sanderling Ventures

ViaCyte (formerly Novocell) raised $80M on November 29, 2018

Investors: TPG Global, RA Capital Management, L.P. and Sanderling Ventures

Metavention, Inc. raised $65M on January 8, 2018

Investors: Versant Ventures and Sanderling Ventures

SpecificiT Pharma Inc. raised undisclosed on September 11, 2017

Investors: Accel-Rx - Canada's Health Science Accelerator and Sanderling Ventures

PreciThera, Inc. raised $29M on July 27, 2017

Investors: Arix Bioscience plc, Emerillon Capital and Sanderling Ventures

Glycomine Inc. raised $12M on November 16, 2016

Investors: Chiesi Ventures and Sanderling Ventures

Torax Medical, Inc. raised $25M on July 26, 2016

Investors: Thomas, McNerney & Partners, Accuitive Medical Ventures, Mayo Clinic Ventures, Piper Jaffray and Sanderling Ventures